Zepbound’s starting dose is typically 2.5 milligrams (mg) once per week. Your doctor will gradually increase it, up to a maximum weekly dose of 15 mg. Zepbound’s maintenance dosage ranges from 5 to 15 ...
The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...
If you’ve been comparing tirzepatide vs semaglutide and hearing names like Ozempic, Wegovy, Mounjaro, or Zepbound everywhere, ...
People on weight-loss drugs like Ozempic may not need to jab themselves nearly as often as they think, a small new study suggests. Researchers at Scripps Health followed 30 patients on GLP-1 ...
Currently, the 5mg/0.5mL and 12.5mg/0.5mL dosage strengths are in short supply due to an increase in demand for the drug. Certain dosage strengths of Zepbound ™ (tirzepatide) will be in limited supply ...
Eli Lilly has rolled out a multi-dose KwikPen version of tirzepatide, marketed as Zepbound, for chronic weight management—signaling a packaging update for one of the obesity market’s fastest-expanding ...
Novo Nordisk’s CagriSema has been outperformed by Eli Lilly’s Zepbound (tirzepatide) in a head-to-head obesity trial. The ...
Medicare Part D plans may cover Zepbound if it is prescribed for obstructive sleep apnea (OSA), as this drug has FDA approval for this condition in individuals living with obesity. Medicare typically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results